Results 11 to 20 of about 213,160 (266)

Targeting Aggrephagy for the Treatment of Alzheimer’s Disease

open access: yesCells, 2020
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases in older individuals with specific neuropsychiatric symptoms. It is a proteinopathy, pathologically characterized by the presence of misfolded protein (Aβ and Tau ...
Sandeep Malampati   +14 more
doaj   +1 more source

Clinical Characteristics of Involuntary Movement in Hospitalized Patients [PDF]

open access: yesJournal of Movement Disorders, 2019
Objective Neurological symptoms in hospitalized patients are not rare, and neurological consultation for movement disorders is especially important in evaluating or managing those with various movement disorders.
Kyum-Yil Kwon   +3 more
doaj   +1 more source

Deep learning algorithm reveals two prognostic subtypes in patients with gliomas

open access: yesBMC Bioinformatics, 2022
Background Gliomas are highly complex and heterogeneous tumors, rendering prognosis prediction challenging. The advent of deep learning algorithms and the accessibility of multi-omic data represent a new approach for the identification of survival ...
Jing Tian   +10 more
doaj   +1 more source

Palliative care for Parkinson’s disease: suggestions from a council of patient and carepartners

open access: yesnpj Parkinson's Disease, 2017
In 2015, the Parkinson’s Disease Foundation sponsored the first international meeting on Palliative Care and Parkinson’s disease and the Patient Centered Outcomes Research Institute funded the first comparative effectiveness trial of palliative care for ...
Kirk Hall   +4 more
doaj   +1 more source

How Cognition and Motivation “Freeze” the Motor Behavior in Parkinson’s Disease

open access: yesFrontiers in Neuroscience, 2019
ObjectiveFreezing of gait (FoG) is a debilitating problem in patients with PD. The multifactorial pathogenesis of FoG remains poorly understood. We aimed to find which factors are most strongly associated with the occurrence of FoG.MethodsThree hundred ...
Paola Ortelli   +9 more
doaj   +1 more source

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience

open access: yesFrontiers in Neuroscience, 2021
The international Linked Clinical Trials (iLCT) program for Parkinson’s to date represents one of the most comprehensive drug repurposing programs focused on one disease.
Simon R. W. Stott   +2 more
doaj   +1 more source

Additional file 2: of Responsiveness of the short-form health survey and the Parkinsonâ s disease questionnaire in patients with Parkinsonâ s disease

open access: yes, 2017
Internal responsiveness of HRQoL in the stable patient group. (DOCX 20 kb)
Tu, Xiao-Jing   +3 more
openaire   +1 more source

MOESM2 of White matter damage and systemic inflammation in Parkinsonâ s disease

open access: yes, 2017
Additional file 2: Partial correlation between DTI indices and clinical disease severity.
Chiang, Pi-Ling   +7 more
openaire   +1 more source

MOESM1 of White matter damage and systemic inflammation in Parkinsonâ s disease

open access: yes, 2017
Additional file 1: Supplementary methods of DTI data preprocessing and analysis.
Chiang, Pi-Ling   +7 more
openaire   +1 more source

Additional file 1: of Cerebellar involvement in Parkinsonâ s disease resting tremor

open access: yes, 2016
Summary Analysis Data. (DOCX 13 kb)
Lefaivre, Shannon   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy